Assessing the appropriate use of proton pump inhibitors amongst the outpatient lebanese population

LAUR Repository

Show simple item record

dc.contributor.author Na'was, Tarek
dc.contributor.author Nawas, George T.
dc.contributor.author Malaeb, Diana
dc.contributor.author El Helou, Sarah
dc.contributor.author Hallit, Souheil
dc.date.accessioned 2018-11-29T13:16:36Z
dc.date.available 2018-11-29T13:16:36Z
dc.date.copyright 2016 en_US
dc.date.issued 2018-11-29
dc.identifier.issn 2319-7706 en_US
dc.identifier.uri http://hdl.handle.net/10725/9826
dc.description.abstract Proton pump inhibitors (PPI) are commonly prescribed for the treatment of many conditions but are currently being misused. The objective of this study was to evaluate the appropriate indication, dosage and duration of use of PPIs by outpatients in Lebanon. This cross-sectional study evaluated the treatment of 323 outpatients who presented to community pharmacies, in different Lebanese regions, with any PPI prescription. The results showed that there was a significant association between the prescribing of the PPI for the correct indication and recommending it in the appropriate dosage, but not with the type of PPI used nor with the duration of treatment that was indicated. No significant difference was found between the prescribed and over-the-counter PPIs regarding the appropriate duration of treatment, dosage and indication. A significant association was found, however, between the reason for PPI use and the other chronic diseases that the patients had and the number of cups of coffee drunk by a patient per day. PPI use by Lebanese outpatients showed to be mostly consistent with the FDA recommendations with regards to the dosage taken. However, the duration of therapy was clearly not in accordance with what is currently recommended. Physicians need to follow-up with patients and reassess the need for therapy on a regular basis. en_US
dc.language.iso en en_US
dc.title Assessing the appropriate use of proton pump inhibitors amongst the outpatient lebanese population en_US
dc.type Article en_US
dc.description.version Published en_US
dc.author.school SAS en_US
dc.author.idnumber 198029370 en_US
dc.author.department Natural Sciences en_US
dc.description.embargo N/A en_US
dc.relation.journal International Journal of Current Microbiology and Applied Sciences en_US
dc.journal.volume 5 en_US
dc.journal.issue 1 en_US
dc.article.pages 767-777 en_US
dc.keywords Proton pump inhibitors en_US
dc.keywords Heartburn en_US
dc.keywords Ulcer en_US
dc.keywords GERD en_US
dc.keywords Lebanon en_US
dc.keywords Community pharmacy en_US
dc.identifier.doi http://dx.doi.org/10.20546/ijcmas.2016.510.083 en_US
dc.identifier.ctation Nawas, G. T., Nawas, T., Malaeb, D., El Helou, S., & Hallit, S. (2016). Assessing the appropriate use of proton pump inhibitors amongst the outpatient Lebanese population. Int. J. Curr. Microbiol. App. Sci, 5(10), 767-777. en_US
dc.author.email tnawas@lau.edu.lb en_US
dc.identifier.tou http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php en_US
dc.identifier.url https://www.ijcmas.com/abstractview.php?ID=1021&vol=5-10-2016&SNo=83 en_US
dc.author.affiliation Lebanese American University en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search LAUR

Advanced Search


My Account